A study published in the European Journal of Clinical Nutrition found that premeal consumption of protein combined with dietary fiber significantly augmented the GLP-1 response and reduced total energy intake by 16% (view study)
Pos1013 how does body mass index affect secukinumab treatment outcomes and safety in patients with psoriatic arthritis
A prospective study involving individuals initiated on semaglutide, evaluated via ultrasound after an overnight fast, demonstrated that 70% of those receiving semaglutide exhibited retained solid gastric content, in contrast to 10% in the control group [17]
The company has not published efficacy data and did not respond to a request for information
Important safety warnings seek urgent medical attention if you experience: Severe or persistent abdominal pain, which may radiate to the back this could indicate pancreatitis , a serious but rare risk associated with GLP-1based therapies as a class [16] [17] Right upper quadrant pain, fever, or jaundice these may suggest gallbladder disease , another class-associated risk Signs of dehydration (dizziness, reduced urine output, extreme thirst) resulting from severe vomiting or diarrhoea, which can affect kidney function Pregnancy and breastfeeding: Use of GLP-1based therapies and related investigational agents is not recommended during pregnancy or breastfeeding
Retatrutide Coming Soon Retatrutide is an investigational weight loss medication showing promising results in reducing body weight in adults with obesity or overweight
